表紙
市場調查報告書

肝癌治療藥的全球市場

Liver Cancer Drugs

出版商 Global Industry Analysts, Inc. 商品編碼 912748
出版日期 內容資訊 英文 143 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
肝癌治療藥的全球市場 Liver Cancer Drugs
出版日期: 2019年10月01日內容資訊: 英文 143 Pages
簡介

本報告提供全球肝癌治療藥市場概要,彙整趨勢·發展的影響因素分析,競爭企業與市場佔有率,世界及地區·各主要國家的市場規模的變化與預測,主要企業簡介等資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球肝癌治療藥市場上企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美國家
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東
    • 非洲

第4章 競爭企業

  • BAYER AG
  • BRISTOL-MYERS SQUIBB COMPANY
  • Eisai
  • EXELIXIS
  • MERCK & CO., INC.

第5章 調查資料

目錄
Product Code: MCP-6297

Liver Cancer Drugs market worldwide is projected to grow by US$1.5 Billion, driven by a compounded growth of 19.5%. Targeted Therapy, one of the segments analyzed and sized in this study, displays the potential to grow at over 20.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$1.3 Billion by the year 2025, Targeted Therapy will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 17.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$54.9 Million to the region's size and clout in the next 5 to 6 years. Over US$45.8 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Targeted Therapy will reach a market size of US$59.9 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 24.9% over the next couple of years and add approximately US$369.1 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Bayer AG; Bristol-Myers Squibb Company; Eisai Co., Ltd.; Exelixis, Inc.; Merck & Co., Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Liver Cancer Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Liver Cancer Drugs Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
  • TABLE 2: Liver Cancer Drugs Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017
  • TABLE 3: Liver Cancer Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Targeted Therapy (Drug Class) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 5: Targeted Therapy (Drug Class) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 6: Targeted Therapy (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Immunotherapy (Drug Class) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 8: Immunotherapy (Drug Class) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 9: Immunotherapy (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Liver Cancer Drugs Market Share (in %) by Company: 2019 & 2025
    • TABLE 10: United States Liver Cancer Drugs Market Estimates and Projections in US$ Thousand by Drug Class: 2018 to 2025
    • TABLE 11: Liver Cancer Drugs Market in the United States by Drug Class: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 12: United States Liver Cancer Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 13: Canadian Liver Cancer Drugs Market Estimates and Forecasts in US$ Thousand by Drug Class: 2018 to 2025
    • TABLE 14: Canadian Liver Cancer Drugs Historic Market Review by Drug Class in US$ Thousand: 2009-2017
    • TABLE 15: Liver Cancer Drugs Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • JAPAN
    • TABLE 16: Japanese Market for Liver Cancer Drugs: Annual Sales Estimates and Projections in US$ Thousand by Drug Class for the Period 2018-2025
    • TABLE 17: Liver Cancer Drugs Market in Japan: Historic Sales Analysis in US$ Thousand by Drug Class for the Period 2009-2017
    • TABLE 18: Japanese Liver Cancer Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 19: Chinese Liver Cancer Drugs Market Growth Prospects in US$ Thousand by Drug Class for the Period 2018-2025
    • TABLE 20: Liver Cancer Drugs Historic Market Analysis in China in US$ Thousand by Drug Class: 2009-2017
    • TABLE 21: Chinese Liver Cancer Drugs Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Liver Cancer Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 22: European Liver Cancer Drugs Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
    • TABLE 23: Liver Cancer Drugs Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017
    • TABLE 24: European Liver Cancer Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 25: European Liver Cancer Drugs Market Estimates and Forecasts in US$ Thousand by Drug Class: 2018-2025
    • TABLE 26: Liver Cancer Drugs Market in Europe in US$ Thousand by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 27: European Liver Cancer Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 28: Liver Cancer Drugs Market in France by Drug Class: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 29: French Liver Cancer Drugs Historic Market Scenario in US$ Thousand by Drug Class: 2009-2017
    • TABLE 30: French Liver Cancer Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 31: Liver Cancer Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Drug Class for the Period 2018-2025
    • TABLE 32: German Liver Cancer Drugs Historic Market Analysis in US$ Thousand by Drug Class: 2009-2017
    • TABLE 33: German Liver Cancer Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 34: Italian Liver Cancer Drugs Market Growth Prospects in US$ Thousand by Drug Class for the Period 2018-2025
    • TABLE 35: Liver Cancer Drugs Historic Market Analysis in Italy in US$ Thousand by Drug Class: 2009-2017
    • TABLE 36: Italian Liver Cancer Drugs Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 37: United Kingdom Market for Liver Cancer Drugs: Annual Sales Estimates and Projections in US$ Thousand by Drug Class for the Period 2018-2025
    • TABLE 38: Liver Cancer Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Drug Class for the Period 2009-2017
    • TABLE 39: United Kingdom Liver Cancer Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 40: Spanish Liver Cancer Drugs Market Estimates and Forecasts in US$ Thousand by Drug Class: 2018 to 2025
    • TABLE 41: Spanish Liver Cancer Drugs Historic Market Review by Drug Class in US$ Thousand: 2009-2017
    • TABLE 42: Liver Cancer Drugs Market in Spain: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 43: Russian Liver Cancer Drugs Market Estimates and Projections in US$ Thousand by Drug Class: 2018 to 2025
    • TABLE 44: Liver Cancer Drugs Market in Russia by Drug Class: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 45: Russian Liver Cancer Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 46: Rest of Europe Liver Cancer Drugs Market Estimates and Forecasts in US$ Thousand by Drug Class: 2018-2025
    • TABLE 47: Liver Cancer Drugs Market in Rest of Europe in US$ Thousand by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 48: Rest of Europe Liver Cancer Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 49: Asia-Pacific Liver Cancer Drugs Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
    • TABLE 50: Liver Cancer Drugs Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2009-2017
    • TABLE 51: Asia-Pacific Liver Cancer Drugs Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 52: Liver Cancer Drugs Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 53: Asia-Pacific Liver Cancer Drugs Historic Market Scenario in US$ Thousand by Drug Class: 2009-2017
    • TABLE 54: Asia-Pacific Liver Cancer Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 55: Liver Cancer Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Drug Class for the Period 2018-2025
    • TABLE 56: Australian Liver Cancer Drugs Historic Market Analysis in US$ Thousand by Drug Class: 2009-2017
    • TABLE 57: Australian Liver Cancer Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 58: Indian Liver Cancer Drugs Market Estimates and Forecasts in US$ Thousand by Drug Class: 2018 to 2025
    • TABLE 59: Indian Liver Cancer Drugs Historic Market Review by Drug Class in US$ Thousand: 2009-2017
    • TABLE 60: Liver Cancer Drugs Market in India: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 61: Liver Cancer Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Drug Class for the Period 2018-2025
    • TABLE 62: South Korean Liver Cancer Drugs Historic Market Analysis in US$ Thousand by Drug Class: 2009-2017
    • TABLE 63: Liver Cancer Drugs Market Share Distribution in South Korea by Drug Class: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 64: Rest of Asia-Pacific Market for Liver Cancer Drugs: Annual Sales Estimates and Projections in US$ Thousand by Drug Class for the Period 2018-2025
    • TABLE 65: Liver Cancer Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Drug Class for the Period 2009-2017
    • TABLE 66: Rest of Asia-Pacific Liver Cancer Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 67: Latin American Liver Cancer Drugs Market Trends by Region/Country in US$ Thousand: 2018-2025
    • TABLE 68: Liver Cancer Drugs Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 69: Latin American Liver Cancer Drugs Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 70: Latin American Liver Cancer Drugs Market Growth Prospects in US$ Thousand by Drug Class for the Period 2018-2025
    • TABLE 71: Liver Cancer Drugs Historic Market Analysis in Latin America in US$ Thousand by Drug Class: 2009-2017
    • TABLE 72: Latin American Liver Cancer Drugs Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 73: Argentinean Liver Cancer Drugs Market Estimates and Forecasts in US$ Thousand by Drug Class: 2018-2025
    • TABLE 74: Liver Cancer Drugs Market in Argentina in US$ Thousand by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 75: Argentinean Liver Cancer Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 76: Liver Cancer Drugs Market in Brazil by Drug Class: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 77: Brazilian Liver Cancer Drugs Historic Market Scenario in US$ Thousand by Drug Class: 2009-2017
    • TABLE 78: Brazilian Liver Cancer Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 79: Liver Cancer Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Drug Class for the Period 2018-2025
    • TABLE 80: Mexican Liver Cancer Drugs Historic Market Analysis in US$ Thousand by Drug Class: 2009-2017
    • TABLE 81: Mexican Liver Cancer Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 82: Rest of Latin America Liver Cancer Drugs Market Estimates and Projections in US$ Thousand by Drug Class: 2018 to 2025
    • TABLE 83: Liver Cancer Drugs Market in Rest of Latin America by Drug Class: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 84: Rest of Latin America Liver Cancer Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 85: The Middle East Liver Cancer Drugs Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
    • TABLE 86: Liver Cancer Drugs Market in the Middle East by Region/Country in US$ Thousand: 2009-2017
    • TABLE 87: The Middle East Liver Cancer Drugs Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 88: The Middle East Liver Cancer Drugs Market Estimates and Forecasts in US$ Thousand by Drug Class: 2018 to 2025
    • TABLE 89: The Middle East Liver Cancer Drugs Historic Market by Drug Class in US$ Thousand: 2009-2017
    • TABLE 90: Liver Cancer Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • IRAN
    • TABLE 91: Iranian Market for Liver Cancer Drugs: Annual Sales Estimates and Projections in US$ Thousand by Drug Class for the Period 2018-2025
    • TABLE 92: Liver Cancer Drugs Market in Iran: Historic Sales Analysis in US$ Thousand by Drug Class for the Period 2009-2017
    • TABLE 93: Iranian Liver Cancer Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 94: Israeli Liver Cancer Drugs Market Estimates and Forecasts in US$ Thousand by Drug Class: 2018-2025
    • TABLE 95: Liver Cancer Drugs Market in Israel in US$ Thousand by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 96: Israeli Liver Cancer Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 97: Saudi Arabian Liver Cancer Drugs Market Growth Prospects in US$ Thousand by Drug Class for the Period 2018-2025
    • TABLE 98: Liver Cancer Drugs Historic Market Analysis in Saudi Arabia in US$ Thousand by Drug Class: 2009-2017
    • TABLE 99: Saudi Arabian Liver Cancer Drugs Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 100: Liver Cancer Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Drug Class for the Period 2018-2025
    • TABLE 101: United Arab Emirates Liver Cancer Drugs Historic Market Analysis in US$ Thousand by Drug Class: 2009-2017
    • TABLE 102: Liver Cancer Drugs Market Share Distribution in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 103: Liver Cancer Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Drug Class for the Period 2018-2025
    • TABLE 104: Rest of Middle East Liver Cancer Drugs Historic Market Analysis in US$ Thousand by Drug Class: 2009-2017
    • TABLE 105: Rest of Middle East Liver Cancer Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 106: African Liver Cancer Drugs Market Estimates and Projections in US$ Thousand by Drug Class: 2018 to 2025
    • TABLE 107: Liver Cancer Drugs Market in Africa by Drug Class: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 108: African Liver Cancer Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

IV. COMPETITION

  • BAYER AG
  • BRISTOL-MYERS SQUIBB COMPANY
  • EISAI CO.
  • EXELIXIS
  • MERCK & CO., INC.

V. CURATED RESEARCH

Back to Top